Network origin in Mark Meltz first degree
Entity | Entity type | Industry | |
---|---|---|---|
87
| Public Company | Pharmaceuticals: Major | 87 |
Subsidiary | Pharmaceuticals: Major | 22 | |
Subsidiary | Biotechnology | 16 | |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.
14
| Subsidiary | Internet Software/Services | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Meltz via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Human Resources Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Washington University in St. Louis | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
CITIGROUP INC. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Executive Officer Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Massachusetts Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Founder Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Chairman Founder Director/Board Member Director/Board Member Founder | |
Stanford University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal Director of Finance/CFO Founder | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree | |
Fondation Santé | Director/Board Member Founder Founder | ||
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
University of California, Los Angeles | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member President Chief Operating Officer | |
EXELIXIS, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
University of California | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Xinthera, Inc.
Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Biotechnology | Director/Board Member Founder | |
Georgetown University | College/University | Director/Board Member Director/Board Member | |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Bentley University | College/University | Graduate Degree Graduate Degree | |
SYNLOGIC, INC. | Biotechnology | General Counsel Chief Executive Officer |
Statistics
International
United States | 46 |
Bermuda | 2 |
Germany | 2 |
Greece | 2 |
China | 2 |
Sectoral
Health Technology | 27 |
Consumer Services | 15 |
Finance | 5 |
Commercial Services | 4 |
Electronic Technology | 2 |
Operational
Director/Board Member | 665 |
Corporate Officer/Principal | 275 |
Independent Dir/Board Member | 200 |
Chairman | 96 |
Undergraduate Degree | 87 |
Most connected contacts
Insiders | |
---|---|
James Tananbaum | 60 |
Carl Gordon | 59 |
Eric Rowinsky | 36 |
Marijn Dekkers | 35 |
Louis Lange | 35 |
George Scangos | 33 |
Steven Holtzman | 28 |
Hans-Peter Hasler | 28 |
Caroline Dorsa | 27 |
Faheem Hasnain | 27 |
Stephen Sherwin | 26 |
Howard Rosen | 26 |
Stelios Papadopoulos | 26 |
Alexander Denner | 25 |
Douglas Williams | 25 |
- Stock Market
- Insiders
- Mark Meltz
- Company connections